Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 149
Appendix C
Registered Workshop Attendees
Olusoji Adeyi Amy Bloom
Sector Manager Acting Chief, Infectious Diseases
World Bank Division
USAID
Vincent Ahonkhai
Senior Regulatory Affairs Officer Barry Bloom
Gates Foundation Harvard University Distinguished
Service Professor and Joan L.
Sarah Alphs and Julius H. Jacobson Professor
Research Associate of Public Health
The William Davidson Institute at Harvard School of Public Health
the University of Michigan
Anthony Boni
Rifat Atun Pharmaceutical Specialist
Professor of International Health USAID
Management
Imperial College London Gail Cassell
Visiting Professor
Jim Barrington Harvard Medical School
Global Progam Director
Novartis Peter Cegielski
Team Leader for Drug-Resistant
TB
U.S. Centers for Disease Control
and Prevention
149
OCR for page 150
150 GLOBAL SUPPLY CHAIN FOR SECOND-LINE DRUGS FOR MDR TB
Rajni Chandrasekhar Jose Gomez-Marquez
Consultant Director
FSG Social Impact Consultants MIT Little Devices Lab
Gordon Comstock Andrew Gray
Director, Global Supply Chain Senior Lecturer, Pharmaceutical
Partnership for Supply Chain Sciences
Management School of Health Sciences
University of KwaZulu-Natal
Henk den Besten
Senior Supply Chain Advisor Carol Hamilton
Partnership for Supply Chain Senior Scientist
Management FHI 360
Lucica Ditiu Debra Hanna
Executive Secretary Associate Director, CPTR
World Health Organization, Critical Path Institute
Stop TB Partnership
Lisa Hedman
Suzanne Essama-Bibi Project Manager
TB Technical Advisor World Health Organization
FHI 360
Myriam Henkens
David Ferreira International Medical Coordinator
Managing Director for Innovative Médecins Sans Frontières
Finance
GAVI Alliance Brad Herbert
Managing Director
Gary Filerman Brad Herbert Associates
President
Atlas Health Foundation Julia Hipps
Senior Director
Hamish Fraser Eli Lilly and Company
Assistant Professor of Medicine
Director of Informatics and Maria Insua
Telemedicine Senior Technical Advisor
Partners In Health University Research Co., LLC
Harvard Medical School
Douglas Keene
Anne Goldfeld Vice President
Professor of Medicine Center for Pharmaceutical
Global Health Committee Management
Harvard Medical School Management Sciences for Health
OCR for page 151
APPENDIX C 151
Joël Keravec Sana Mostaghim
Brazil Country Program Director MDR TB Drug Access Project
Management Sciences for Health Manager
Clinton Health Access Initiative
Salmaan Keshavjee
Director, Program in Infectious Betsy Myers
Disease and Social Change Program Director for Medical
Harvard Medical School Research
Doris Duke Charitable Foundation
Michael Kimerling
Senior Program Officer, Norbert Ndjeka
Tuberculosis Global Health MDR TB Director
Program Department of Health, South
Bill & Melinda Gates Foundation Africa
Jenna Kohnke Meg O’Brien
Program Manager Director, Global Access to Pain
American Cancer Society Relief Initiative
American Cancer Society
Paul Lalvani
Director and Dean Christophe Perrin
Empower School of Health QA Pharmacist
International Union Against
Patrick Lukulay Tuberculosis and Lung Disease
Vice President
Global Health Impact Programs Claire Queresi
USP Senior Program Officer
Results for Development Institute
Robert Matiru (R4D)
TB Portfolio Manager
UNITAID Iain Richardson
World Health Organization Senior Director, Global Supply
Chain and Logistics
Montserrat Meiro-Lorenzo Eli Lilly and Company
Senior Public Health Specialist
World Bank David Ripin
Executive Vice President of Access
Thomas Moore Programs and Chief Scientific
World Health Organization, Stop Officer
TB Partnership Clinton Health Access Initiative
OCR for page 152
152 GLOBAL SUPPLY CHAIN FOR SECOND-LINE DRUGS FOR MDR TB
Owen Robinson Trish Stroman
Program Manager Principal
Partners In Health The Boston Consulting Group
Paul Ryu Jami Taylor
Regional Manager of Western Senior Director, Global Access
Europe Policy
Dong-A Pharmaceutical Co., Ltd. Janssen, The Pharmaceutical
Companies of Johnson &
Nina Schwalbe Johnson
Managing Director, Policy and
Performance Cheri Vincent
GAVI Alliance TB Team Leader
USAID
Robert Sebbag
Vice President, Access to Medicines Brenda Waning
Sanofi Coordinator, Market Dynamics
UNITAID
Andreas Seiter World Health Organization
Senior Health Specialist
World Bank Prashant Yadav
Director, Healthcare Research
Pooja Shaw Initiative
Program Officer University of Michigan
Results for Development Institute
(R4D) Andre Zagorski
Principal Technical Advisor for
Tracy Sims TB, Center for Pharmaceutical
Vice President Management
Eli Lilly & Co. Foundation Management Sciences for Health
Robert Stanley
Manager
Partnership for Supply Chain
Management
